| abstract |
The present invention relates to a compound of formula (I) and a pharmaceutically acceptable salt thereof, a process for preparing the compound, an intermediate for preparing the compound, a pharmaceutical composition containing the compound and the use of the compound in the treatment of Use in a method of a disease or condition in a mammal selected from central nervous system disorders, cognitive disorders, schizophrenia, dementia and other disorders. |